Combined TACE and sorafenib for HCC treatment
نویسندگان
چکیده
منابع مشابه
Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis
BACKGROUND AND AIM A large number of studies have tried to combine sorafenib with TACE for patients with unresectable hepatocellular carcinoma (HCC) and the results were controversial. We conducted this systematic review and meta-analysis to evaluate the safety and efficacy of combination therapy of sorafenib and TACE in the management of unresectable HCC. METHODS MEDLINE, PsycINFO, Scopus, E...
متن کاملCombination of sorafenib and TACE inhibits portal vein invasion for intermediate stage HCC: a single center retrospective controlled study
Purpose This study aims to investigate the effect of sorafenib plus Transarterial Chemoembolization (TACE) treatment on inhibiting portal vein invasion in patients with intermediate stage HCC. Materials and Methods The consecutive medical records of patients with HCC were retrospectively analyzed from October 2009 to February 2015. The propensity score matching method was applied into group m...
متن کاملTransarterial chemoembolization (TACE) for unresectable HCC: a new life begins?
BACKGROUND AND OBJECTIVES To provide an overview on the loco-regional therapy performed by transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC), either as sole, either as neoadjuvant to surgery or bridge therapy to orthotopic liver transplantation (OLT). EVIDENCE AND INFORMATION SOURCES The current review is based on an analysis of the current literature and ...
متن کاملTumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients
BACKGROUND Suppressor of cytokine signaling (SOCS) 1 and 3 methylation have been associated with clinical features and outcomes of cancer patients. However, their roles in determining the treatment response to transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) remain unknown. RESULTS We found that presence of SOCS3 methylation is significantly associated wi...
متن کاملAfp after Tace as a Predictor of Survival in Hcc
The incidence of hepatocellular carcinoma (hcc) in North America has nearly doubled since the early 1990s, paralleling the rising incidence of hepatitis C virus–related cirrhosis1–3. Hepatocellular carcinoma is often diagnosed late and has a 5-year survival rate of 11% in the United States4. Transplantation is a therapeutic option unique to hcc among malignancies, having been brought to the for...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Gastroenterology & Hepatology
سال: 2020
ISSN: 1759-5045,1759-5053
DOI: 10.1038/s41575-020-0265-0